DE3573884D1 - Substained release tablets and method for preparation thereof - Google Patents

Substained release tablets and method for preparation thereof

Info

Publication number
DE3573884D1
DE3573884D1 DE8585110591T DE3573884T DE3573884D1 DE 3573884 D1 DE3573884 D1 DE 3573884D1 DE 8585110591 T DE8585110591 T DE 8585110591T DE 3573884 T DE3573884 T DE 3573884T DE 3573884 D1 DE3573884 D1 DE 3573884D1
Authority
DE
Germany
Prior art keywords
preparation
terpolymer
pore
coating
release tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585110591T
Other languages
English (en)
Inventor
Stig Albin Bertil Erlandsson
Ake Rikard Lindahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GACELL LABORATORIES AB, MALMOE, SE
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Application granted granted Critical
Publication of DE3573884D1 publication Critical patent/DE3573884D1/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Seal Device For Vehicle (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
DE8585110591T 1982-07-08 1985-08-23 Substained release tablets and method for preparation thereof Expired DE3573884D1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39639182A 1982-07-08 1982-07-08
EP85110591A EP0211991B1 (de) 1982-07-08 1985-08-23 Tabletten mit verzögerter Freisetzung sowie Verfahren zu deren Herstellung
CA000489999A CA1251731A (en) 1982-07-08 1985-09-04 Sustained release tablets and method for preparation thereof

Publications (1)

Publication Number Publication Date
DE3573884D1 true DE3573884D1 (en) 1989-11-30

Family

ID=37102089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585110591T Expired DE3573884D1 (en) 1982-07-08 1985-08-23 Substained release tablets and method for preparation thereof

Country Status (9)

Country Link
EP (1) EP0211991B1 (de)
JP (1) JPH0764725B2 (de)
AT (1) ATE47519T1 (de)
AU (1) AU574220B2 (de)
CA (1) CA1251731A (de)
DE (1) DE3573884D1 (de)
DK (1) DK153520C (de)
FI (1) FI86373C (de)
PT (1) PT81091B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2572618B2 (ja) * 1988-01-22 1997-01-16 日産自動車株式会社 自動車用ドアのグラスラン構造
IE60383B1 (en) * 1988-05-27 1994-07-13 Elan Corp Plc Controlled release pharmaceutical formulation
JPH0647530B2 (ja) * 1990-02-03 1994-06-22 ユニコロイド株式会社 腸疾患用薬剤カプセル及びその製法
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
CA2232489A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
SE9903879D0 (sv) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
JP4680061B2 (ja) * 2003-08-20 2011-05-11 塩野義製薬株式会社 新規コーティング組成物
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
EP2018860A1 (de) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
EP1938840A1 (de) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
WO2008077939A2 (en) * 2006-12-27 2008-07-03 Lek Pharmaceuticals D.D. Duloxetine composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
SE324859B (de) * 1967-09-04 1970-06-15 Ercopharm As
US3595939A (en) * 1968-12-27 1971-07-27 Tenneco Chem Process for the production of vinyl chloride/vinyl alcohol copolymers
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
WO1983002056A1 (en) * 1981-12-18 1983-06-23 Key Pharma Expandable lattice of polyvinyl alcohol and polyethylene glycol
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4432965A (en) * 1982-07-09 1984-02-21 Key Pharmaceuticals, Inc. Quinidine sustained release dosage formulation

Also Published As

Publication number Publication date
EP0211991A1 (de) 1987-03-04
FI853407L (fi) 1987-03-06
FI853407A0 (fi) 1985-09-05
JPS6256419A (ja) 1987-03-12
ATE47519T1 (de) 1989-11-15
JPH0764725B2 (ja) 1995-07-12
DK153520B (da) 1988-07-25
EP0211991B1 (de) 1989-10-25
CA1251731A (en) 1989-03-28
AU4693485A (en) 1987-03-05
DK400785A (da) 1987-03-03
DK400785D0 (da) 1985-09-02
DK153520C (da) 1988-12-05
FI86373C (fi) 1992-08-25
FI86373B (fi) 1992-05-15
AU574220B2 (en) 1988-06-30
PT81091B (pt) 1988-01-22
PT81091A (en) 1985-10-01

Similar Documents

Publication Publication Date Title
DE3573884D1 (en) Substained release tablets and method for preparation thereof
SE8504720L (sv) Ny lekemedelsberedning
PT87423A (pt) Process of preparation of a pharmaceutical granule the base of cimetidine and of of form of pharmaceutical dosage in tablets
ES541513A0 (es) Procedimiento para la obtencion de comprimidos de sustancia activa farmaceutica, de rapida desintegracion
NL190812C (nl) Werkwijze voor de bereiding van 1,4-dihydropyridinederivaten met vaatverwijdende en bloeddrukverlagende werking, alsmede farmaceutische preparaten die deze derivaten omvatten.
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
SE8600402D0 (sv) Forfarande for behandling av doseringsformer
ES8702138A1 (es) Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
EP0411952A3 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
DE19975013I1 (de) 2.Oxo-Imidazolidin-Verbindungen Verfahren zu derenHerstellung und pharmazeutische Zusammensetzung
SE8803822D0 (sv) Novel dosage form
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
DE68905613D1 (de) Pharmazeutische zubereitung.
FR2604901B1 (fr) Procede de preparation de comprimes a dissolution et/ou delitement rapide et comprimes ainsi obtenus
FR2627986B1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations
NO164958C (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.
ES8704080A1 (es) Metodo para producir una tableta farmaceutica revestida esencialmente con un terpolimero de poli (cloruro de vinilo) poli (acetato de vinilo) y poli (alcohol vinilico)
ATE62409T1 (de) Neue arzneimittelzubereitung mit geregelter verabreichung des aktiven mittels, und deren herstellungsverfahren.
ES2008753A6 (es) Procedimiento de preparacion de una composicion farmaceutica de liberacion controlada.
NL7803977A (nl) 2,-hydroxy-2-(5-isoxazolylmethyl)-6,7-benzomorfanen, zuuradditiezouten daarvan alsmede farmaceutische preparaten die deze verbindingen bevatten.
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
KE2872A (en) Process for the preparation of the o,o-dimethyl-o-(2,2-dichlorovinyl) ester and the o,o-diethyl-o-(2,2-dichlorovinyl) ester of thionophosporic acid
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DIB LTD., ST. JOHNS, ISLE OF MAN, GB

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8327 Change in the person/name/address of the patent owner

Owner name: GACELL LABORATORIES AB, MALMOE, SE